Honored for the opportunity to present our research at the 2023 American Society of Hematology (ASH) Summit on Immunotherapies for Hematological Diseases about the utility of a platform to combat healthcare inequity and connect patients to immunotherapeutic clinical trials (pleasure collaborating with the amazing team at IFF Technologies) and a promising approach to treat severe SARS-CoV-2 in multiple myeloma patient using cell therapies.